Although the first of them have ascribed a pathogenic role of TNFRSF13B/TACI alterations in CVID [1, 2], further studies suggested that these mutations might represent modifiers of the disease, since they are also present in healthy individuals, without any evidence of immunodeficiency [3, 4]. This evidence concerns the gene TNFRSF13B and immune system disorder.